UPDATE 1-Israel’s Teva Pharma appoints Lundbeck’s Kare Schultz as CEO

JERUSALEM, Sept 11 (Reuters) – Teva PharmaceuticalIndustries Ltd named H Lundbeck A/S ChiefExecutive Kare Schultz as its new CEO and president on Monday,as it struggles with heavy debts and fierce competition for itsgeneric drugs in the United States.
The post UPDATE 1-Israel’s Teva Pharma appoints Lundbeck’s Kare Schultz as CEO appeared first on RocketNews | Top News Stories From Around the Globe.